SPAC Overview
Timeline Progress
About
Drugs Made In America Acquisition Corp. is a blank-check company seeking a business combination, with an intended focus on the pharmaceutical industry. Its stated strategy includes supporting U.S.-based pharmaceutical production and supply-chain resilience.
Investment Focus
Biopharmaceuticals
Geographic Focus
United States
The terms and the filing trail behind Drugs Made In America Acquisition Corp.
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Leadership
Underwriters
Extended Team Information
Led by CEO and Executive Chair Lynn Stockwell, a pharmaceutical and healthcare entrepreneur, and CFO Glenn Worman, an experienced finance executive with prior SPAC experience. The director nominees bring medical research and drug-discovery expertise, biopharmaceutical experience, and legal experience.